NovaBay Pharmaceuticals I... (NBY)
AMEX: NBY
· Real-Time Price · USD
0.55
-0.05 (-9.06%)
At close: Aug 15, 2025, 3:30 PM
0.62
13.30%
After-hours: Aug 15, 2025, 03:58 PM EDT
NovaBay Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 7.67M | -1.21M | -1.34M | -1.58M | -3.09M | -4.11M | -1.76M | -2.04M | -1.74M | -8.21M | -136K | -2.15M | -111K | -158K | -2.29M | -1.86M | -1.52M |
Depreciation & Amortization | 55K | 95K | 9K | 11K | 12K | 50K | 51K | 51K | 51K | 123K | 119K | 120K | 121K | 87K | 12K | 11K | 9K |
Stock-Based Compensation | 2K | 11K | 22K | 55K | 60K | 90K | 62K | 64K | 75K | 90K | -208K | 154K | 184K | 448K | 228K | 294K | 183K |
Other Working Capital | n/a | 269K | 632K | -69K | -90K | -66K | 165K | -36K | 69K | -159K | 252K | 128K | 39K | -224K | 8.62M | 10.38M | -186K |
Other Non-Cash Items | n/a | -95K | -354K | 393K | 1.31M | 3.12M | 947K | 486K | 246K | 5.49M | -492K | 340K | -2.27M | -4.14M | -13K | 13K | 108K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 531K | -285K | n/a | -246K | n/a | n/a | -340K | n/a | -473K | n/a | n/a | n/a |
Change in Working Capital | n/a | 229K | -287K | 230K | 57K | 537K | 619K | -408K | 2K | 1.3M | -972K | 182K | 24K | -80K | 581K | -446K | -93K |
Operating Cash Flow | -1.32M | -972K | -1.95M | -674K | -1.59M | -314K | -363K | -1.84M | -1.61M | -1.21M | -1.69M | -1.7M | -2.06M | -4.32M | -1.47M | -1.99M | -1.42M |
Capital Expenditures | n/a | n/a | -2K | -2K | -2K | -2K | -2K | -2K | -13K | -32K | -80K | -8K | -24K | -8K | -17K | -2K | -25K |
Cash Acquisitions | n/a | -1.07M | n/a | n/a | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.99M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 1.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -11.99M | n/a | n/a | n/a |
Investing Cash Flow | n/a | -1.07M | -2K | -2K | 1.07M | -2K | -2K | -2K | -13K | -32K | -80K | -8K | -24K | -12M | -17K | -2K | -25K |
Debt Repayment | n/a | 500K | -790K | -622K | -578K | n/a | n/a | 2.81M | n/a | n/a | n/a | n/a | n/a | 105K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -218K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -115K | 2.88M | 130K | -19K | -26K | -577K | -294K | n/a | 3.04M | 1.7M | n/a | -105K | 14.91M | n/a | 1.77M | n/a |
Financial Cash Flow | n/a | 385K | 2.09M | -396K | -578K | -139K | -577K | 2.51M | n/a | 3.04M | 1.7M | -105K | -105K | 14.79M | 219K | 1.77M | n/a |
Net Cash Flow | 8.04M | -346K | 26K | -1.07M | -1.31M | -342K | -942K | 668K | -1.62M | 1.83M | -66K | -1.71M | -2.19M | -1.52M | -1.27M | -214K | -1.44M |
Free Cash Flow | -1.32M | -972K | -1.95M | -676K | -1.59M | -203K | -365K | -1.84M | -1.62M | -1.24M | -1.77M | -1.71M | -2.08M | -4.33M | -1.49M | -1.99M | -1.44M |